2024 AAAAI Drug Hypersensitivity Research Grant
Award amount and duration:
Applicants must meet the following requirements to be eligible:
- Be board certified in allergy/immunology by the American Board of Allergy and Immunology (ABAI) or
- hold the equivalent certification from the Royal College of Physicians and Surgeons of Canada (RCPSC).
- At the time of Letter of Intent (August 2023), applicant must be at or below the level of Associate
- Professor (or equivalent).
- Primary faculty appointment must be in the discipline of allergy/immunology.
- One of the following degrees:
- MD, PhD
- DO, PhD
- Citizen or permanent resident of the United States or Canada.
- A member of the AAAAI.
This funding opportunity is to support research grant(s) to advance the state of knowledge, develop novel techniques, agents, methodologies, models, or applications that could have a significant impact on drug hypersensitivity research. This funding mechanism is designed to further research in drug allergy/hypersensitivity for individuals with a current or future focus in drug hypersensitivity research. Priority will be given to junior faculty and those without current NIH funding. For the purpose of this opportunity vaccines are not considered drugs, and applications that focus on vaccine reactions will NOT be considered for this award.
This two-year award will provide for direct costs (salary, lab expenses, etc.) ranging from $50,000 - $150,000
(dispersed to the awardees institution in four equal payments). Award term is July 1, 2024, to June 30, 2026.
Funds may not be used for institutional indirect costs.
Letter of Intent and Full Application (invitation only) submitted via the AAAAI website:
Not applicable. Funds may not be used for institutional indirect costs.
RSO internal deadline
Pre-application program deadline
RSO detailed review deadline
RSO final internal review deadline
Program application deadline
NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.
Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.
Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:
- Principal Investigator
- Department Head
- Faculty ADR/Dean
- Research Services (on behalf of the Vice-President Research)
Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.
Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.
American Academy of Allergy Asthma and Immunology